Becky Crean, Ph.D.

Executive Director, Clinical Development, Ionis

Dr. Crean is Executive Director, Clinical Development at Ionis Pharmaceuticals and leads the clinical development of Ionis’ antisense oligonucleotide therapy programs for several rare, neurological disorders. Dr. Crean has more than a decade of experience in clinical development across the spectrum of neurodevelopmental to neurodegenerative diseases. Prior to joining Ionis, Dr. Crean was a senior researcher at The Scripps Research Institute, where she led translational research programs studying the impact of neurological disorders on brain functioning.